|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7097 USD | +7.79% |
|
-6.07% | +23.90% |
| Mar. 14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
Vaxart, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 7.38 million compared to USD 0.107 million a year ago. Net loss was USD 82.47 million compared to USD 107.76 million a year ago.
Basic loss per share from continuing operations was USD 0.57 compared to USD 0.84 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.90% | 126M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
VAXART, INC. 
